These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20234160)

  • 1. Severe vancomycin-induced anaphylactic reaction.
    Kupstaite R; Baranauskaite A; Pileckyte M; Sveikata A; Kadusevicius E; Muckiene G
    Medicina (Kaunas); 2010; 46(1):30-3. PubMed ID: 20234160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Firvanq--vancomycin oral solution.
    Med Lett Drugs Ther; 2018 Jul; 60(1551):122. PubMed ID: 30036349
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management.
    Changela A; Javaiya H; Rickenback K; Elnawawi A; Changela K
    Am J Ther; 2013; 20(2):223-5. PubMed ID: 21273948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome.
    Hassaballa H; Mallick N; Orlowski J
    Am J Ther; 2000 Sep; 7(5):319-20. PubMed ID: 11317179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin: a 50-something-year-old antibiotic we still don't understand.
    Schilling A; Neuner E; Rehm SJ
    Cleve Clin J Med; 2011 Jul; 78(7):465-71. PubMed ID: 21724929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful vancomycin desensitization with a combination of rapid and slow infusion methods.
    Kitazawa T; Ota Y; Kada N; Morisawa Y; Yoshida A; Koike K; Kimura S
    Intern Med; 2006; 45(5):317-21. PubMed ID: 16596002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin levels, efficacy, and toxicity.
    Johnson JR
    Arch Intern Med; 2007 Jun; 167(11):1207; author reply 1208-9. PubMed ID: 17563035
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant
    Lv C; Lv J; Liu Y; Liu Q; Zou D
    Int J Immunopathol Pharmacol; 2020; 34():2058738420925713. PubMed ID: 32567423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Shen WC; Chiang YC; Chen HY; Chen TH; Yu FL; Tang CH; Sue YM
    Nephrology (Carlton); 2011 Nov; 16(8):697-703. PubMed ID: 21707841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
    Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
    Trials; 2016 Mar; 17():170. PubMed ID: 27029920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopsy proven interstitial nephritis following treatment with vancomycin: a case report.
    Salazar MN; Matthews M; Posadas A; Ehsan M; Graeber C
    Conn Med; 2010 Mar; 74(3):139-41. PubMed ID: 20391819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New target concentrations for vancomycin in Hong Kong.
    You JH; Chow SS; Lui JW; Ip M
    Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycopeptide-induced vasculitis--cross-reactivity between vancomycin and teicoplanin.
    Marshall C; Street A; Galbraith K
    J Infect; 1998 Jul; 37(1):82-3. PubMed ID: 9733391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is high minimal inhibitory concentration of vancomycin a predictor of poor response in MRSA infections?
    Faulhaber G; Zavascki A; Fuchs SC
    Arch Intern Med; 2007 Jun; 167(11):1206-7; author reply 1208-9. PubMed ID: 17563032
    [No Abstract]   [Full Text] [Related]  

  • 20. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Máiz L; Cantón R; Mir N; Baquero F; Escobar H
    Pediatr Pulmonol; 1998 Oct; 26(4):287-9. PubMed ID: 9811080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.